查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年 mRNA 合成原材料的全球市場規模研究和預測，按產品、應用、最終用戶、地區分析
市場調查報告書
商品編碼
1258080

2022-2029 年 mRNA 合成原材料的全球市場規模研究和預測，按產品、應用、最終用戶、地區分析

Global mRNA Synthesis Raw Material Market Size study & Forecast, by Product by Application, by End-user and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021 年 mRNA 合成原材料的全球市場價值為 27.46 億美元，預計在 2022-2029 年的預測期內將以 2.1% 的複合年增長率增長。

mRNA 是使用由 DNA 核甘酸序列組成的模板在細胞核中通過轉錄過程產生的。 mRNA的適應性和靈活性使其成為開發針對各種慢性病和傳染病的治療性和預防性疫苗的絕佳平台。 癌症和慢性病發病率的增加增加了對基因治療的需求。

由於對基因治療的需求不斷增長以及慢性病和傳染病的增加，預計未來幾年 mRNA 合成和製造服務市場將顯著增長。 許多市場進入者和研究機構正在獲得資金來開發新的 mRNA 療法。 例如，2022年10月，加拿大政府向哥倫比亞大學提供了1110萬美元，用於進一步開發其mRNA疫苗。 在當前的 Covid-2019 大流行期間，許多公司選擇了 mRNA 疫苗技術來對抗冠狀病毒。 同樣，2022 年 12 月，ExPLoRNA Therapeutics 從比爾和梅琳達蓋茨基金會獲得了 813,578 美元的資金，用於進一步開發其 mRNA 技術。 預計多個市場參與者的新參與將進一步推動市場。 由於缺乏靈活、耐用且價格合理的製造程序，阻礙了 mRNA 合成原材料的開發。 原材料的高成本是進步的主要障礙。

全球 mRNA 合成原料市場研究考慮的主要區域包括亞太地區、北美、歐洲、拉丁美洲和拉丁美洲其他地區。 用於mRNA合成的原材料市場主要由北美主導。 由於輝瑞和摩德納等知名公司擁有大型 mRNA 疫苗生產設施，預計美國仍將保持行業領先地位。 因此，該地區有望在預測期內保持其主導地位。 全球mRNA合成原料市場以亞太地區為主，由於研發成本上升、傳染病流行和尖端技術的快速引進，預計該地區增長最快。

本研究的目的是闡明近年來各個細分市場和國家/地區的市場規模，並預測未來幾年的市場規模。 該報告旨在捕捉被調查國家行業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還包含供利益相關者投資的潛在微觀市場機會，以及對主要參與者的競爭格局和產品供應的深入分析。

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年全球和細分市場估計和預測
    • 2019-2029 年按地區劃分的 mRNA 合成原材料市場
    • mRNA 合成原材料市場，按類型劃分，2019-2029 年
    • mRNA 合成原材料市場，按應用分類，2019-2029 年
    • mRNA 合成原材料市場，按最終用戶分類，2019-2029 年
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第2章全球mRNA合成原料市場的定義和範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 本次調查涵蓋的年份
  • 貨幣兌換率

第3章全球mRNA合成原料市場動態

  • mRNA合成原料市場影響分析（2019-2029）
    • 市場驅動力
      • 癌症和慢性病的發病率增加
      • 主要製藥公司的積極參與
    • 市場挑戰
      • mRNA 合成原料成本高
    • 市場機會
      • COVID-19 造成的必然性
      • mRNA的優勢很大

第四章全球mRNA合成材料市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 投資招聘模式
  • 分析師的建議和結論
  • 主要投資機會
  • 關鍵成功策略

第 5 章風險評估：COVID-19 的影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章 mRNA 合成原材料的全球市場：按類型分類

  • 市場概況
  • 全球 mRNA 合成原材料市場：按類型、性能和潛力分析
  • 2019-2029 年全球 mRNA 合成原材料市場類型的估計和預測
  • mRNA 合成原料市場，細分市場分析
    • 封蓋劑
    • 核甘酸
    • 質粒DNA
    • 其他

第 7 章 mRNA 合成原材料的全球市場：按應用分類

  • 市場概況
  • mRNA 合成原材料的全球市場：按應用和性能進行的潛力分析
  • 2019-2029年版全球mRNA合成原料市場預估及預測（分應用）
  • mRNA 合成原料市場，細分市場分析
    • 治療藥物的生產
    • 疫苗製造
    • 其他

第 8 章 mRNA 合成原材料的全球市場：按最終用戶分類

  • 市場概況
  • mRNA 合成原材料的全球市場：最終用戶的性能潛力分析
  • 2019-2029 年最終用戶合成 mRNA 原材料的全球市場估計和預測
  • mRNA 合成原料市場，細分市場分析
    • 生物製藥和製藥公司
    • 首席風險官/首席營銷官
    • 學術和研究機構

第 9 章全球 mRNA 合成原材料市場：區域分析

  • mRNA 合成原材料市場，按地區劃分的市場概況
  • 北美
    • 美國
      • 按類型估算和預測，2019-2029 年
      • 按應用分類的估計和預測，2019-2029 年
      • 2019-2029 年最終用戶的估計和預測
    • 加拿大
  • 歐洲 mRNA 合成原料市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲
  • 亞太地區 mRNA 合成原料市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲 mRNA 合成原料市場概況
    • 巴西
    • 墨西哥
  • 世界其他地區

第 10 章衝突信息

  • 主要市場策略
  • 公司簡介
    • 輝瑞公司
      • 關鍵信息
      • 概覽
      • 財務（僅當數據可用時）
      • 類型概述
      • 近期趨勢
    • Moderna, Inc.
    • BioNTech SE
    • Bayer AG
    • GlaxoSmithKline
    • Boehringer Ingelheim
    • CureVac
    • Sarepta Therapeutics
    • Alnylam Pharmaceuticals
    • Ionis Pharmaceuticals

第 11 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查的特點
  • 調查先決條件

Global mRNA synthesis raw material market is valued at approximately USD2746 million in 2021and and is anticipated to expand at a compound annual growth rate (CAGR) of 2.1% over the forecast period 2022-2029.Using a template consisting of the DNA nucleotide sequence, mRNA is created by the transcription process in the nucleus.mRNA's adaptability and flexibility make it an excellent platform for developing therapeutic or preventive vaccines for a range of chronic and infectious diseases.The growing incidence of cancer and chronic disorders has raised the demand for gene treatments.

The market for mRNA synthesis and manufacturing services is expected to increase significantly over the next few years as a result of the rising demand for gene therapies, and the rise in chronic and infectious diseases. Funding is being provided for the creation of new mRNA therapies to numerous market participants and research institutions. For instance, the Canadian government provided USD 11.1 million in financing to the University of Columbia in October 2022 to further the development of mRNA vaccines. During the current Covid-2019 pandemic, many companies have chosen mRNA vaccine technology to combat coronavirus. Similarly, in December 2022, ExPLoRNA Therapeutics received USD 813,578 in funding from the Bill & Melinda Gates Foundation to further develop its mRNA technology. The emerging involvement of several market players is expected to drive the market further. The development of mRNA synthesis raw materials is hampered by a lack of adaptive, durable, and reasonably priced manufacturing procedures. The high cost of raw resources is the main impediment to progress.

The key regions considered for the Global mRNA synthesis raw material market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market for raw materials used in mRNA synthesis. The United States is forecasted to keep up its position as the industry leader because ofthe existence of sizable mRNA vaccine production facilities by renowned companies such asPfizer and Moderna. Due to this, this region will maintain its dominance throughout the forecast period. A significant percentage of the global market for mRNA synthesis raw materials was owned by Asia Pacific, which is anticipated to be the fastest-growing region due to rising R&D expenditures, a growth in the prevalence of infectious diseases, and a quick uptake of cutting-edge technology.

Major market players included in this report are:

  • Pfizer Inc.
  • Moderna, Inc.
  • BioNTech SE
  • Bayer AG
  • GlaxoSmithKline
  • Boehringer Ingelheim
  • CureVac
  • Sarepta Therapeutics
  • Alnylam Pharmaceuticals
  • Ionis Pharmaceuticals

Recent Developments in the Market:

  • In November 2022, The BASE and Sartorius formed an alliance to facilitate the sharing of development methodologies and strategies for various nucleic acid-based products. The collaboration will enable the efficient application of cutting-edge methods and analytical thinking to design and plan techniques for nucleic acid products.
  • Thermo Fisher Scientific unveiled a customised Dynabeads solution in October 2022, claiming that it aids in the synthesis and purification of mRNA for use in developing and manufacturing vaccines.
  • A final deal was signed by Sanofi in August 2021 to buy all of the outstanding shares of Translate Bio, a company that develops therapies for messenger RNA (mRNA). The purchase is a component of Sanofi's goal to hasten the application of mRNA technology in the creation of pharmaceuticals and vaccines.

Global mRNA synthesis raw material marketReport Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Type, application, end-user, region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporatespotential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

  • Capping Agents
  • Nucleotides
  • Plasmid DNA
  • Others

By Application:

  • Therapeutics Production
  • Vaccine Production
  • Others

By End-user:

  • Biopharmaceutical & Pharmaceutical Companies CROs & CMOs
  • Academic & Research Institutions

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. mRNA Synthesis Raw Material Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. mRNA Synthesis Raw Material Market, by Type,2019-2029 (USD Million)
    • 1.2.3. mRNA synthesis raw material Market, by Application, 2019-2029 (USD Million)
    • 1.2.4. mRNA synthesis raw material Market, by End-user, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global mRNA Synthesis Raw Material Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global mRNA Synthesis Raw Material Market Dynamics

  • 3.1. mRNA Synthesis Raw Material Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of cancer and chronic disorders
      • 3.1.1.2. Active Involvement of big pharma players
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of mRNA Synthesis Raw Material
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Necessity created by COVID-19
      • 3.1.3.2. Considerable benefits of mRNA

Chapter 4. Global mRNA Synthesis Raw Material Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global mRNA Synthesis Raw Material Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global mRNA Synthesis Raw Material Market by Type, Performance - Potential Analysis
  • 6.3. Global mRNA Synthesis Raw Material Market Estimates & Forecasts by Type 2019-2029 (USD Million)
  • 6.4. mRNA Synthesis Raw Material Market, Sub Segment Analysis
    • 6.4.1. Capping Agents
    • 6.4.2. Nucleotides
    • 6.4.3. Plasmid DNA
    • 6.4.4. Others

Chapter 7. Global mRNA synthesis raw material Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global mRNA synthesis raw material Market by Application, Performance - Potential Analysis
  • 7.3. Global mRNA synthesis raw material Market Estimates & Forecasts by Application2019-2029 (USD Million)
  • 7.4. mRNA synthesis raw material Market, Sub Segment Analysis
    • 7.4.1. Therapeutics Production
    • 7.4.2. Vaccine Production
    • 7.4.3. Others

Chapter 8. Global mRNA synthesis raw material Market, by End-user

  • 8.1. Market Snapshot
  • 8.2. Global mRNA Synthesis Raw Material Market by End-user, Performance - Potential Analysis
  • 8.3. Global mRNA synthesis raw material Market Estimates & Forecasts by End-user 2019-2029 (USD Million)
  • 8.4. mRNA synthesis raw material Market, Sub Segment Analysis
    • 8.4.1. Biopharmaceutical & Pharmaceutical Companies
    • 8.4.2. CROs & CMOs
    • 8.4.3. Academic & Research Institution

Chapter 9. Global mRNA Synthesis Raw Material Market, Regional Analysis

  • 9.1. mRNA Synthesis Raw Material Market, Regional Market Snapshot
  • 9.2. North America mRNA Synthesis Raw Material Market
    • 9.2.1. U.S.mRNA Synthesis Raw Material Market
      • 9.2.1.1. Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. End-user breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada mRNA Synthesis Raw Material Market
  • 9.3. Europe mRNA Synthesis Raw Material Market Snapshot
    • 9.3.1. U.K. mRNA Synthesis Raw Material Market
    • 9.3.2. Germany mRNA Synthesis Raw Material Market
    • 9.3.3. France mRNA Synthesis Raw Material Market
    • 9.3.4. Spain mRNA Synthesis Raw Material Market
    • 9.3.5. Italy mRNA Synthesis Raw Material Market
    • 9.3.6. Rest of Europe mRNA Synthesis Raw Material Market
  • 9.4. Asia-Pacific mRNA Synthesis Raw Material Market Snapshot
    • 9.4.1. China mRNA Synthesis Raw Material Market
    • 9.4.2. India mRNA Synthesis Raw Material Market
    • 9.4.3. Japan mRNA Synthesis Raw Material Market
    • 9.4.4. Australia mRNA Synthesis Raw Material Market
    • 9.4.5. South Korea mRNA Synthesis Raw Material Market
    • 9.4.6. Rest of Asia Pacific mRNA Synthesis Raw Material Market
  • 9.5. Latin America mRNA Synthesis Raw Material Market Snapshot
    • 9.5.1. Brazil mRNA Synthesis Raw Material Market
    • 9.5.2. Mexico mRNA Synthesis Raw Material Market
  • 9.6. Rest of The World mRNA Synthesis Raw Material Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Pfizer Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Type Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Moderna, Inc.
    • 10.2.3. BioNTech SE
    • 10.2.4. Bayer AG
    • 10.2.5. GlaxoSmithKline
    • 10.2.6. Boehringer Ingelheim
    • 10.2.7. CureVac
    • 10.2.8. Sarepta Therapeutics
    • 10.2.9. Alnylam Pharmaceuticals
    • 10.2.10. Ionis Pharmaceuticals

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global mRNA Synthesis Raw Material Market, report scope
  • TABLE 2. Global mRNA Synthesis Raw Material Market estimates & forecasts by Region 2019-2029 (USD Million)
  • TABLE 3. Global mRNA Synthesis Raw Material Market estimates & forecasts byType2019-2029 (USD Million)
  • TABLE 4. Global mRNA synthesis raw material Market estimates & forecasts by Application2019-2029 (USD Million)
  • TABLE 5. Global mRNA synthesis raw material Market estimates & forecasts by End-user2019-2029 (USD Million)
  • TABLE 6. Global mRNA Synthesis Raw Material Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 7. Global mRNA Synthesis Raw Material Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 8. Global mRNA Synthesis Raw Material Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 9. Global mRNA Synthesis Raw Material Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 10. Global mRNA Synthesis Raw Material Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 11. Global mRNA Synthesis Raw Material Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 12. Global mRNA Synthesis Raw Material Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 13. Global mRNA Synthesis Raw Material Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 14. Global mRNA Synthesis Raw Material Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 15. Global mRNA Synthesis Raw Material Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 16. U.S. mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 17. U.S. mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 18. U.S. mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 19. Canada mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 20. Canada mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 21. Canada mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 22. UK mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 23. UK mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 24. UK mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 25. Germany mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 26. Germany mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 27. Germany mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 28. France mRNA synthesis raw material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 29. France mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 30. France mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 31. Italy mRNA synthesis raw material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 32. Italy mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 33. Italy mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 34. Spain mRNA synthesis raw material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 35. Spain mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 36. Spain mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 37. RoE mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 38. RoE mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 39. RoE mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 40. China mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 41. China mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 42. China mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 43. India mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 44. India mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 45. India mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 46. Japan mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 47. Japan mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 48. Japan mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 49. South Korea mRNA synthesis raw material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 50. South Korea mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 51. South Korea mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 52. Australia mRNA synthesis raw material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 53. Australia mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 54. Australia mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 55. RoAPAC mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 56. RoAPAC mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 57. RoAPAC mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 58. Brazil mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 59. Brazil mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 60. Brazil mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 61. Mexico mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 62. Mexico mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 63. Mexico mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 64. RoLA mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 65. RoLA mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 66. RoLA mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 67. Row mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 68. Row mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 69. Row mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 70. List of secondary sources, used in the study of global mRNA Synthesis Raw Material Market
  • TABLE 71. List of primary sources, used in the study of global mRNA Synthesis Raw Material Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global mRNA Synthesis Raw Material Market, research methodology
  • FIG 2. Global mRNA Synthesis Raw Material Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global mRNA Synthesis Raw Material Market, key trends 2021
  • FIG 5. Global mRNA Synthesis Raw Material Market, growth prospects 2022-2029
  • FIG 6. Global mRNA Synthesis Raw Material Market, porters 5 force model
  • FIG 7. Global mRNA Synthesis Raw Material Market, pest analysis
  • FIG 8. Global mRNA Synthesis Raw Material Market, value chain analysis
  • FIG 9. Global mRNA Synthesis Raw Material Market by segment, 2019 & 2029 (USD Million)
  • FIG 10. Global mRNA Synthesis Raw Material Market by segment, 2019 & 2029 (USD Million)
  • FIG 11. Global mRNA Synthesis Raw Material Market by segment, 2019 & 2029 (USD Million)
  • FIG 12. Global mRNA Synthesis Raw Material Market by segment, 2019 & 2029 (USD Million)
  • FIG 13. Global mRNA Synthesis Raw Material Market by segment, 2019 & 2029 (USD Million)
  • FIG 14. Global mRNA Synthesis Raw Material Market, regional snapshot 2019 & 2029
  • FIG 15. North America mRNA Synthesis Raw Material Market2019 & 2029 (USD Million)
  • FIG 16. Europe mRNA Synthesis Raw Material Market2019 & 2029 (USD Million)
  • FIG 17. Asia pacific mRNA Synthesis Raw Material Market2019 & 2029 (USD Million)
  • FIG 18. Latin America mRNA Synthesis Raw Material Market2019 & 2029 (USD Million)
  • FIG 19. Global mRNA Synthesis Raw Material Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable